Skip to main content
Caplight Logo









Harness Therapeutics

Harness Therapeutics

Private
CambridgeHealthcare & Life Scienceshttps://www.harnesstx.com/

Last Round

Grant

Jun 9, 2026

Total Funding Raised

$18.69M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Harness Therapeutics is a biotechnology company developing next-generation therapeutics to transform the treatment of neurodegenerative diseases through precision protein upregulation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neurodegenerative diseaseoligonucleotide therapeuticsASOantisense oligonucleotideprotein modulationdrug discoveryprecision medicineRNA therapeuticsbiotech platformHuntington's diseaseundruggable targetsbioinformaticstherapeutic pipelineRNA medicineneuro biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Harness Therapeutics Comparables

Compare Harness Therapeutics with similar companies based on industry and business-model similarity.

Harness Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vico Therapeutics
83%
Atalanta Therapeutics
78%
LoQus23 Therapeutics
71%

Harness Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 9, 2026
VC RoundJan 27, 2025
VC RoundNov 28, 2023
SeedMay 31, 2022
SeedJun 2, 2021

Key People

Founding team and executive leadership

Jan Thirkettle

Chief Executive Officer

Executive Team

Julia Jones

Fractional CFO

Executive Team

Madeleine Wakeling

Chief Operating Officer

Executive Team

Harness Therapeutics Investors

Notable investors and investment history

Harness Therapeutics investors
InvestorRounds
SV Health InvestorsVC Round, Seed
Epidarex CapitalVC Round, Seed
The Michael J. Fox Foundation for Parkinson's ResearchGrant
Ono Venture Investment, Inc.VC Round
OVI PartnersVC Round
Takeda VenturesVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 9, 2026

    Received grant from The Michael J. Fox Foundation.

  • Oct 7, 2025

    Partnered with Ono Venture Investment for research.

Harness Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Harness Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Harness Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range35
Year Founded2020
Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?